Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes.
Daujat
M
M
Pichard
L
L
Fabre
I
I
Pineau
T
T
Fabre
G
G
Bonfils
C
C
Maurel
P
P
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002478:Cells, Cultured; D046508:Culture Techniques / Q000379:methods; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis*; D003907:Dexamethasone / Q000494:pharmacology; D004790:Enzyme Induction; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D005333:Fetus; D006801:Humans; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D011247:Pregnancy; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012293:Rifampin / Q000494:pharmacology; D012727:Sex Characteristics; D014217:Troleandomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011285:Pregnenolone Carbonitrile; D004917:Erythromycin; D003907:Dexamethasone; D003577:Cytochrome P-450 Enzyme System; D014217:Troleandomycin; D012293:Rifampin